x Brown

Benchmark Reports Fourth Quarter and Full Year 2020 Results

Fourth quarter 2020 results:
– Revenue of $521 million
– GAAP gross margin of 9.7% and non-GAAP gross margin of 9.6%
– Cash flow generated from operations of $95 million
– GAAP diluted EPS of $0.21 and non-GAAP diluted EPS of $0.34
Full year 2020 results:
– Revenue of $2.1 billion
– Semi-Cap revenue growth of 33% year-over-year
– Medical revenue growth of 11% year-over-year
– Higher-value markets revenue mix greater than 80%

Jeff Benck, Benchmark’s President and CEO stated, “We closed out a very challenging year, delivering fourth quarter results that not only met our expectations, but demonstrated sequential improvement in both non-GAAP gross margins at 9.6% and higher non-GAAP earnings at $0.34 enabled by higher-value sector mix and improved utilization across the company.  I am very proud of our team, which has proven to be very resourceful and resilient in the face of this pandemic and continues to deliver for our customers.”

Benck continued, “Our focused efforts on improving working capital management are also bearing fruit as we generated $95 million of operating cash flow in the quarter and over $120 million for the year, which exceeded our forecast.  I look forward to 2021 with optimism knowing that our strategic investments in the business to drive differentiated value and sustainability have solidified a path to achieve revenue, margin, and earnings growth in 2021 aligned with our mid-term financial goals.”

Fourth Quarter 2020 Industry Sector Update
Revenue and percentage of sales by industry sector (in millions) was as follows.

Dec 31,

Sep 30,

Dec 31,

Higher-Value Markets

2020

2020

2019

Medical

$

111

21

%

$

134

26

%

$

103

20

%

Semi-Cap

101

20

99

19

81

16

A&D

111

21

105

20

106

21

Industrials

97

19

86

16

107

21

$

420

81

%

$

424

81

%

$

397

78

%

Dec 31,

Sep 30,

Dec 31,

Traditional Markets

2020

2020

2019

Computing

$

46

9

%

$

44

8

%

$

45

9

%

Telecommunications

55

10

58

11

66

13

$

101

19

%

$

102

19

%

$

111

22

%

Total

$

521

100

%

$

526

100

%

$

508

100

%

Overall, higher-value market revenues were up 6% year-over-year from strength in the Semi-Cap, Medical, and A&D sectors. Traditional market revenues were down from program transitions.

First Quarter 2021 Outlook

  • Revenue between $480 – $520 million
  • Diluted GAAP earnings per share between $0.11 – $0.14
  • Diluted non-GAAP earnings per share between $0.18 – $0.22 (excluding restructuring charges and other costs and amortization of intangibles)
  • This guidance takes into consideration all known constraints for the quarter and assumes no further significant interruptions to our supply base, operations or customers. Guidance also assumes no material changes to end market conditions due to COVID-19.

Restructuring charges are expected to range between $1.0 million and $2.0 million in the first quarter and the amortization of intangibles is expected to be $2.0 million in the first quarter.

Fourth Quarter 2020 and CY2020 Earnings Conference Call
The Company will host a conference call to discuss the results today at 5:00 p.m. Eastern Time.  The live webcast of the call and accompanying reference materials will be accessible by logging on to the Company’s website at www.bench.com. A replay of the broadcast will also be available until Thursday, February 11, 2021 on the Company’s website.